Monument Therapeutics is Drug Delivery in United Kingdom that focus on precision medicine approach business. Founded in 2019. They cover business area such as operator, drug, serious disease, proprietary digital biomarker, heterogeneity, patient, homogenous underlying neurobiology, researcher, advancement, area, unmet medical need.
2019
( 7 years old in 2026 )
Precision Medicine Approach
-
9-10 Tunbridge Court
Bottisham
Cambridge CB25 9TU
England, United Kingdom
Private
operatordrugserious diseaseproprietary digital biomarkerheterogeneitypatienthomogenous underlying neurobiologyresearcheradvancementareaunmet medical need
* We use standard office opening hours in near Monument Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Monument Therapeutics is Drug Delivery business from United Kingdom that founded in 2019 (7 years old in 2026), Monument Therapeutics business is focusing on Precision Medicine Approach.
Monument Therapeutics headquarter office and corporate office address is located in 9-10 Tunbridge Court Bottisham Cambridge CB25 9TU England, United Kingdom.
Monument Therapeutics was founded in United Kingdom.
In 2026, Monument Therapeutics is currently focus on precision medicine approach sector.
Above is snippet of Google Trends for "precision medicine approach" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Monument Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.